Octopus Biosafety (STU:OCR) EBITDA per Share: €-0.06 (TTM As of Dec. 2024)


STU:OCR Octopus Biosafety STU:OCR
6 GF Score
Price €0.10
GF Value €0.04
! 2 Warning Signs
View Full Analysis

What is Octopus Biosafety EBITDA per Share?

Octopus Biosafety STU:OCR 6 EBITDA per Share is €-0.06 as of Dec. 2024. GuruFocus rates STU:OCR with a GF Score™ of 6/100 and a GF Value™ of €0.04. The stock has 2 warning signs investors should review. Among 2,026 Hardware companies, Octopus Biosafety ranks better than 83.51% on this metric.

Octopus Biosafety's EBITDA per Share for the six months ended in Dec. 2024 was €-0.06. Its EBITDA per Share for the trailing twelve months (TTM) ended in Dec. 2024 was €-0.06.

During the past 3 years, the average EBITDA per Share Growth Rate was 28.40% per year. During the past 5 years, the average EBITDA per Share Growth Rate was 35.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per Share growth rate using EBITDA per Share data.

The historical rank and industry rank for Octopus Biosafety's EBITDA per Share or its related term are showing as below:

STU:OCR' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -219.8   Med: 29.3   Max: 42
Current: 28.4

During the past 10 years, the highest 3-Year average EBITDA per Share Growth Rate of Octopus Biosafety was 42.00% per year. The lowest was -219.80% per year. And the median was 29.30% per year.

STU:OCR's 3-Year EBITDA Growth Rate is ranked better than
83.51% of 2026 companies
in the Hardware industry
Industry Median: 1.6 vs STU:OCR: 28.40

Octopus Biosafety's EBITDA for the six months ended in Dec. 2024 was €-0.84 Mil.

During the past 3 years, the average EBITDA Growth Rate was -10.10% per year. During the past 5 years, the average EBITDA Growth Rate was 7.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 10 years, the highest 3-Year average EBITDA Growth Rate of Octopus Biosafety was 32.30% per year. The lowest was -286.90% per year. And the median was -8.80% per year.


Octopus Biosafety  (STU:OCR) EBITDA per Share Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals EBIT. EBIT is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost, it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies.


Octopus Biosafety EBITDA per Share Related Terms


Octopus Biosafety EBITDA per Share Historical Data

* Premium members only.

The historical data trend for Octopus Biosafety's EBITDA per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Octopus Biosafety EBITDA per Share Chart

Octopus Biosafety Annual Data
Trend Jun14 Jun15 Jun16 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBITDA per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.23 -0.16 -0.12 -0.08 -0.06

Octopus Biosafety Semi-Annual Data
Jun14 Jun15 Jun16 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBITDA per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.23 -0.16 -0.12 -0.08 -0.06
STU:OCR
6GF Score
Octopus Biosafety STU:OCR
EBITDA per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Octopus Biosafety EBITDA per Share Calculation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Octopus Biosafety's EBITDA per Share for the fiscal year that ended in Dec. 2024 is calculated as

EBITDA per Share(A: Dec. 2024 )
=EBITDA/Shares Outstanding (Diluted Average)
=-0.837/14.784
=-0.06

Octopus Biosafety's EBITDA per Share for the quarter that ended in Dec. 2024 is calculated as

EBITDA per Share(Q: Dec. 2024 )
=EBITDA/Shares Outstanding (Diluted Average)
=-0.837/14.784
=-0.06

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBITDA per Share for the trailing twelve months (TTM) ended in Dec. 2024 was €-0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA per Share →
What does a EBITDA per Share of €-0.06 mean?
Octopus Biosafety (STU:OCR) has a EBITDA per Share of €-0.06 as of Dec. 2024. EBITDA per share is the per-share amount of earnings before interest, taxes, depreciation and amortization. View historical data on Octopus Biosafety and its competitors. According to the industry distribution chart, Octopus Biosafety ranks #334 out of 2026 companies in the Hardware industry, placing it in the top 16.5%.
Is Octopus Biosafety's EBITDA per Share too high?
Octopus Biosafety's current EBITDA per Share is €-0.06. Based on the distribution chart, Octopus Biosafety ranks #334 out of 2026 companies in the Hardware industry, which is in the top quartile — a strong position relative to peers. Overall, Octopus Biosafety has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Octopus Biosafety's EBITDA per Share compare to SNDK and DELL?
According to the Hardware industry distribution chart, Octopus Biosafety ranks #334 out of 2026 companies for EBITDA per Share. This places Octopus Biosafety in the top 17% of its industry — outperforming the majority of peers. The industry median EBITDA per Share is 1.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA per Share for a Hardware company?
The median EBITDA per Share among Hardware companies is 1.60, based on 2,026 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA per Share significantly above this median, while those in the bottom quartile fall well below. However, EBITDA per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA per Share mean?
A high EBITDA per Share can signal that a stock is expensive relative to its fundamentals. EBITDA per share is the per-share amount of earnings before interest, taxes, depreciation and amortization. View historical data on Octopus Biosafety and its competitors. For the Hardware industry, the median EBITDA per Share is 1.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Octopus Biosafety's current EBITDA per Share is €-0.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Octopus Biosafety stock overvalued right now?
Octopus Biosafety (STU:OCR) has a current EBITDA per Share of €-0.06. The stock's GF Value™ is €0.04, compared to a current price of €0.10 — trading 150% above its estimated fair value. The current EBITDA per Share is €-0.06. Octopus Biosafety's overall GF Score™ is 6/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA per Share calculated?
EBITDA per Share is calculated from a company's financial statements. For Octopus Biosafety (STU:OCR), the current EBITDA per Share is €-0.06 as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Octopus Biosafety (STU:OCR) Overvalued in 2026?

Based on GuruFocus' analysis, Octopus Biosafety stock appears to be overvalued. The current stock price of €0.10 is trading 150% above its estimated GF Value™ of €0.04.

Key valuation signals for STU:OCR:

  • EBITDA per Share: €-0.06
  • GF Value™: €0.04 vs. price of €0.10 (150% above fair value)
  • GF Score™: 6/100 with 2 warning signs

No single metric tells the full story. See the STU:OCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Octopus Biosafety Business Description

Other Exchanges MLOCT:France
Address 29 rue Saint Pierre, Cholet, FRA, 49300
Octopus Biosafety is engaged in the design, manufacture and marketing of mobile, autonomous, intelligent and modular robots for use in Agro-food sector, Healthcare sector, Defense sector, Civil Protection sector, and Surveillance and Transport sector.
6GF Score

Get the complete analysis for STU:OCR

EBITDA per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.10
Price
€0.04
GF Value